Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
Clinical trial NCT06429397 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06429397
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.